Innovations in health have been setting trends, especially in highly complex diseases such as cancer. In this case, A unique situation was experienced by the Australian doctor Richard Scolyer who is recognized in the field of melanoma.
(See: VaxThera will produce 100 million vaccines in Colombia)
However, on this occasion, the same doctor was diagnosed with stage 4 glioblastoma, an aggressive type of brain cancer, and decided to apply his experience and research in an experimental treatment reaching the point of being remitted from this disease.
Treatment was through a combination of targeted therapies and immunotherapyrevealing its effectiveness, since for a year the Australian doctor has remained cancer-free.
(Read: ‘Despite the uncertainty, we guarantee medicines’)
It is worth detailing that this case has taken on international relevance, as it has marked a milestone in the medical sector for treatments against this disease, and where, especially brain cancer has proven to be one of the most resistant to conventional therapies and it also has a survival rate of only 5%.
According to what the doctor told the BBC, despite the fact that he has been cancer-free for a year, this “It doesn’t mean my brain cancer is cured (…) but it’s good to know that it hasn’t come back yet, so I still have more time to enjoy my life with my wife Katie and my three wonderful children.“.
(See more: Fecode calls for an emergency call to its directives for a new teacher health system)
Furthermore, this has represented hope in the population, since one day the research applied in the case of Dr. Scolyer could help the nearly 300,000 people diagnosed with brain cancer each year.
The Australian doctor’s experimental treatment lay in the identification of specific biomarkers that allowed precise therapywhere cutting-edge technologies were also used for the genetic sequencing of cancer cells.
(See also: Deodorant or antiperspirant? How they work and what impact they have on health)
In addition, both Scolyer and his team managed to identify the mutations and alterations in his tumor that made it more susceptible to drugs to treat the disease. Although, It is important to highlight that the treatment was 100% personalized to both the conditions of the disease and the doctor’s body.
This, according to international media It would represent hope for personalized therapies for cancer diseases. And he would also be the first patient to receive combination immunotherapy before surgery and to be administered a personalized vaccine.
(Read more: The two faces of poverty: this is the panorama in terms of health and employment)
This has generated particular interest from the scientific community, which is why the planning of larger-scale clinical trials would be promoted to evaluate the effectiveness in a broader population suffering from the same brain cancer.
Add Comment